A detailed history of Alliancebernstein L.P. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 263,840 shares of ARDX stock, worth $1.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
263,840
Previous 263,840 -0.0%
Holding current value
$1.39 Million
Previous $1.96 Million 7.06%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.89 - $9.31 $262,340 - $414,667
44,540 Added 20.31%
263,840 $1.96 Million
Q2 2023

Aug 15, 2023

BUY
$3.23 - $4.95 $708,339 - $1.09 Million
219,300 New
219,300 $743,000
Q2 2022

Aug 15, 2022

SELL
$0.51 - $1.17 $30,549 - $70,083
-59,900 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$0.65 - $1.18 $195 - $354
300 Added 0.5%
59,900 $64,000
Q3 2021

Nov 10, 2021

SELL
$1.27 - $8.17 $18,288 - $117,648
-14,400 Reduced 19.46%
59,600 $79,000
Q2 2021

Jul 30, 2021

BUY
$6.55 - $8.98 $66,155 - $90,698
10,100 Added 15.81%
74,000 $561,000
Q1 2021

May 06, 2021

SELL
$6.1 - $7.69 $54,900 - $69,210
-9,000 Reduced 12.35%
63,900 $423,000
Q2 2020

Aug 13, 2020

BUY
$5.37 - $8.11 $43,497 - $65,691
8,100 Added 12.5%
72,900 $504,000
Q1 2020

May 14, 2020

BUY
$4.35 - $8.79 $128,324 - $259,304
29,500 Added 83.57%
64,800 $368,000
Q3 2019

Nov 14, 2019

SELL
$2.15 - $6.28 $30,315 - $88,548
-14,100 Reduced 28.54%
35,300 $166,000
Q2 2019

Aug 14, 2019

BUY
$2.49 - $3.73 $7,470 - $11,190
3,000 Added 6.47%
49,400 $133,000
Q1 2019

May 14, 2019

SELL
$1.88 - $3.35 $12,220 - $21,775
-6,500 Reduced 12.29%
46,400 $130,000
Q3 2018

Nov 08, 2018

BUY
$3.75 - $4.65 $15,000 - $18,600
4,000 Added 8.18%
52,900 $230,000
Q2 2018

Aug 13, 2018

BUY
$3.7 - $5.8 $58,460 - $91,640
15,800 Added 47.73%
48,900 $181,000
Q4 2017

Feb 13, 2018

SELL
$4.85 - $7.8 $132,890 - $213,720
-27,400 Reduced 45.29%
33,100 $218,000
Q3 2017

Nov 13, 2017

BUY
$4.35 - $5.7 $263,175 - $344,850
60,500
60,500 $339,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $815M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.